OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) will host an investor R&D Day today beginning at 8:30 a.m. JST in Tokyo. The meeting will focus on programs in the ...
Herriot Tabuteau, CEO, highlighted, "Axsome delivered a strong second quarter, reflecting focused execution across our commercial business and development pipeline. Demand for our end market products ...
Narrow-moat Royalty Pharma’s first-quarter results were in line with our expectations. We are leaving our $52 fair value estimate unchanged and continue to believe the market is undervaluing Royalty ...
Earnings Call Insights: Harmony Biosciences Holdings, Inc. (HRMY) Q2 2025 Management reiterated full year revenue guidance of $820 million to $860 million and maintained their projection that WAKIX is ...
AGOURA HILLS, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) ("OTLC" or the "Company"), a clinical-stage ...
Hosted on MSN
Axsome anticipates expanded market access for SYMBRAVO and AUVELITY while advancing late-stage pipeline
CEO Herriot Tabuteau stated that "Axsome continues to lead in CNS innovation, driven by disciplined execution and a clear focus on sustained growth and value creation." He highlighted strong revenue ...
SAN DIEGO--(BUSINESS WIRE)--Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, today reported positive clinical data from its recently completed ...
Current profits are not necessarily the best guide to selecting pharmaceutical companies for investment. This is because earnings may reflect strong but temporary sales of blockbuster drugs that are ...
In this post, we will explain what is a computer CPU pipeline. CPU (an abbreviation of the Central Processing Unit) is an important part of the computer that functions like a brain. And we already ...
Evan is a writer and entrepreneur with a background in technology and content marketing. He is currently the Head of Growth at Sagetap.io. Previous to Sagetap, he was was co-founder & CEO of the ...
Management reiterated full year revenue guidance of $820 million to $860 million and maintained their projection that WAKIX is "on track to achieve $1 billion plus in annual revenue in narcolepsy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback